BELLEVILLE, ON, April 30 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, presented data at the 4th International Conference on Vaccines for Enteric Diseases, held last week in Lisbon, Portugal. Dr. Dragan Rogan, Vice-President of Animal Health Research & Development with Bioniche Life Sciences Inc. presented a paper entitled, “Vaccination reduces shedding and colonization of E. coli O157:H7 in cattle”, which was co-authored by Dr. Andrew Potter, Vaccine and Infectious Disease Organization (VIDO) - University of Saskatchewan, Dr. David Smith, University of Nebraska-Lincoln, and Colin Strauss, Bioniche Life Sciences Inc.
